rs150168119
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000327.4(ROM1):c.686G>A(p.Arg229His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00279 in 1,614,002 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R229C) has been classified as Uncertain significance.
Frequency
Consequence
NM_000327.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ROM1 | NM_000327.4 | c.686G>A | p.Arg229His | missense_variant | 2/3 | ENST00000278833.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ROM1 | ENST00000278833.4 | c.686G>A | p.Arg229His | missense_variant | 2/3 | 1 | NM_000327.4 | P1 | |
ROM1 | ENST00000534093.5 | c.58G>A | p.Val20Ile | missense_variant | 2/3 | 2 | |||
ROM1 | ENST00000525947.1 | c.58G>A | p.Val20Ile | missense_variant | 2/3 | 3 | |||
ROM1 | ENST00000525801.1 | c.58G>A | p.Val20Ile | missense_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00358 AC: 544AN: 152008Hom.: 3 Cov.: 33
GnomAD3 exomes AF: 0.00344 AC: 864AN: 251468Hom.: 3 AF XY: 0.00337 AC XY: 458AN XY: 135914
GnomAD4 exome AF: 0.00270 AC: 3951AN: 1461876Hom.: 26 Cov.: 33 AF XY: 0.00287 AC XY: 2088AN XY: 727238
GnomAD4 genome AF: 0.00358 AC: 544AN: 152126Hom.: 3 Cov.: 33 AF XY: 0.00403 AC XY: 300AN XY: 74368
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | ROM1: BP4, BS1, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 31, 2014 | - - |
Larsen-like syndrome, B3GAT3 type Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 20, 2020 | - - |
Retinitis pigmentosa Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at